powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1023428570
Daniel Dacosta
Pulmonary Disease
Torrance,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 330059
Hospital
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
27.5
Cost
68.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
356
Unique beneficiaries
—
Total services
406
Distinct HCPCS
15
Medicare payment
$41K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 901 Pulmonary Disease providers in CA — below median (cohort median 927).
PRESCRIBING · PART D · 2024
Total Rx claims
237
Beneficiaries
—
Total drug cost
$70K
Distinct drugs
6
Brand share
86.1%
Top prescribed drugs
Umeclidinium Brm/Vilanterol Tr
92 claims
Albuterol Sulfate
53 claims
Fluticasone/Umeclidin/Vilanter
48 claims
Albuterol Sulfate
11 claims
Pantoprazole Sodium
11 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$155
Payment records
2
By payment type
Food and Beverage
$155